Coming soon · Sunday 25 October · 13:00 CET
SCLC Symposium at ESMO 2026: From IO-Standards to the TCE Era
SymposiumRecording to follow2 CME credits · EACCME & SSMO
Programme & faculty
The Role of Immune Checkpoint Blockade in SCLC: Achievements & Limitations
Martin ReckGermany
Redefining the Standards: The Era of DLL3 T-Cell Engagers
Solange PetersSwitzerland
Practical Management of DLL3 T-Cell Engagers
Giannis MountziosGreece
The Evolving Algorithm: Sequencing Innovative Strategies
Noemí ReguartSpain
Event details
Main Sponsor
Co-Sponsor
Sponsored Content: This symposium was supported by our partner(s) shown above
SCLC Symposium at ESMO 2026: From IO-Standards to the TCE Era
Continue With
Related Topics
Jul
14
2026
ADCs
Advanced NSCLCSCLCADCs
Antibody-drug conjugates across solid tumours: an ETOP/IBCSG expert group sets the research priorities
Read the article
R. StahelS. PetersG. MountziosA. PassaroN. ReguartJ. Remon
Dec
18
2025
VIRTUAL ROUNDTABLE
Advanced NSCLCSCLCADCs
2025 Approvals & Highlights
1 h 49 min
S. PetersC. RudinM. Reck
Sep
26
2025
ILCS 2025
SCLC
Reshaping Approaches in SCLC with the Latest Advances in LS- and ES-Disease
34 min
R. Manochakian
Jun
17
2025
VIRTUAL ROUNDTABLE
SCLCImmunotherapies
Small Cell Lung Cancer
1h 35 min
G. MountziosJ. SandsS. Peters
Oct
04
2024
ILCS 2024
SCLC
Reshaping Our Approaches in SCLC: Latest Therapeutic Options and Future Strategies
25 min
S. Liu